Hypopharyngeal Cancer · Prevention & risk

What are the risk factors for hypopharyngeal cancer?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Hypopharyngeal Cancer Answer length: short, citable
Quick answer

The main recognised risk factors for hypopharyngeal cancer are heavy, long-term tobacco smoking (cigarettes, bidis, pipes), heavy alcohol use — the combination with tobacco is strongly synergistic and plummer–Vinson / Paterson–Kelly syndrome: iron-deficiency anaemia, oesophageal webs and postcricoid carcinoma. Risks differ by region: Eastern Europe & the Baltic states has a distinctive exposure pattern, so a patient's country of residence is part of the risk assessment. Having a risk factor does not mean a person will develop cancer.

In detail

Risk factors are probabilistic. Many patients have no obvious exposure, and most people with an exposure never develop a head and neck tumour. Tell your clinician about all tobacco, areca nut, alcohol, occupational and viral exposures, because this information changes follow-up planning.

  • Heavy, long-term tobacco smoking (cigarettes, bidis, pipes)
  • Heavy alcohol use — the combination with tobacco is strongly synergistic
  • Plummer–Vinson / Paterson–Kelly syndrome: iron-deficiency anaemia, oesophageal webs and postcricoid carcinoma
  • Poor nutrition, low fruit and vegetable intake and micronutrient deficiency
  • Occupational exposures and gastro-oesophageal reflux (weaker associations)
  • Male sex and age over 50; prior head and neck radiotherapy

What this means in practice: this answer is part of the “Prevention & risk” section of the Hypopharyngeal Cancer topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about hypopharyngeal cancer

See all 13 questions in this topic →

Sources for this answer

  1. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 CA: A Cancer Journal for Clinicians · 2026 · Subsite-level estimates for 185 countries; the basis of the regional atlas on this site.
  2. Head and neck cancer: a comprehensive review of epidemiology, global burden and advances in radiotherapy PubMed Central / peer-reviewed review · 2026
  3. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  4. Hypopharyngeal Cancer Treatment (PDQ, health professional version) US National Cancer Institute · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.